Ameriprise Financial Inc Cyma Bay Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

  • $375 Billion
  • Q4 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$12.63 - $24.47 $324,729 - $629,148
25,711 New
25,711 $607,000
Q4 2022

Feb 14, 2023
SELL
$3.22 - $6.27 $22,379 - $43,576
-6,950 Reduced 37.55%
11,561 $72,000
Q3 2022

Nov 14, 2022
SELL
$2.77 - $4.25 $10,387 - $15,937
-3,750 Reduced 16.85%
18,511 $65,000
Q2 2022

Aug 15, 2022
SELL
$1.72 - $3.39 $2,408 - $4,746
-1,400 Reduced 5.92%
22,261 $66,000
Q1 2022

May 16, 2022
BUY
$2.77 - $3.64 $415 - $546
150 Added 0.64%
23,661 $74,000
Q4 2021

Feb 14, 2022
SELL
$3.23 - $4.6 $29,502 - $42,016
-9,134 Reduced 27.98%
23,511 $79,000
Q3 2021

Nov 15, 2021
SELL
$3.47 - $4.42 $5,916 - $7,536
-1,705 Reduced 4.96%
32,645 $120,000
Q2 2021

Aug 16, 2021
SELL
$3.94 - $4.92 $5,023 - $6,273
-1,275 Reduced 3.58%
34,350 $149,000
Q1 2021

May 17, 2021
SELL
$4.23 - $6.55 $34,584 - $53,552
-8,176 Reduced 18.67%
35,625 $161,000
Q4 2020

Feb 12, 2021
BUY
$5.73 - $9.03 $69,361 - $109,308
12,105 Added 38.19%
43,801 $243,000
Q3 2020

Nov 16, 2020
BUY
$3.32 - $7.24 $48,721 - $106,247
14,675 Added 86.22%
31,696 $229,000
Q2 2020

Aug 14, 2020
BUY
$1.41 - $4.25 $23,999 - $72,339
17,021 New
17,021 $60,000
Q4 2019

Feb 14, 2020
SELL
$1.33 - $5.93 $22,633 - $100,916
-17,018 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$5.12 - $7.21 $768 - $1,081
150 Added 0.89%
17,018 $87,000
Q2 2019

Aug 14, 2019
SELL
$6.05 - $13.66 $5,511 - $12,444
-911 Reduced 5.12%
16,868 $121,000
Q1 2019

May 15, 2019
BUY
$8.16 - $13.42 $4,569 - $7,515
560 Added 3.25%
17,779 $236,000
Q4 2018

Feb 14, 2019
BUY
$6.54 - $11.74 $11,379 - $20,427
1,740 Added 11.24%
17,219 $136,000
Q3 2018

Nov 14, 2018
BUY
$10.88 - $14.52 $11,532 - $15,391
1,060 Added 7.35%
15,479 $171,000
Q2 2018

Aug 14, 2018
SELL
$10.66 - $14.38 $790,609 - $1.07 Million
-74,166 Reduced 83.72%
14,419 $194,000
Q1 2018

May 15, 2018
SELL
$9.0 - $15.16 $710,631 - $1.2 Million
-78,959 Reduced 47.13%
88,585 $1.15 Million
Q4 2017

Feb 12, 2018
SELL
$7.67 - $9.31 $176,072 - $213,720
-22,956 Reduced 12.05%
167,544 $1.54 Million
Q3 2017

Nov 07, 2017
BUY
$5.95 - $8.26 $1.13 Million - $1.57 Million
190,500
190,500 $1.54 Million

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email